Pyridines and derivatives
Silver(II) Pyridine-2-carboxylate 97.0+%, TCI America™
CAS: 14783-00-7 Molecular Formula: C12H8AgN2O4-2 Molecular Weight (g/mol): 352.074 InChI Key: ARXVTYGOLNYKET-UHFFFAOYSA-L Synonym: Picolinic Acid Silver(II) Salt, Silver(II) Picolinate, Pyridine-2-carboxylic Acid Silver(II) Salt PubChem CID: 13898161 IUPAC Name: pyridine-2-carboxylate;silver SMILES: C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].[Ag]
TARGETMOL CHEMICALS INC AG-1478 25MG
Also available in 1 mL, 5 mg, 10 mg, 50 mg, 100 mg, 200 mg and bulk. Please contact Fisher for quotes. AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor. Purity 99.03%
Apexbio Technology LLC AG-1295-5MG
AG-1295 (CAS No 71897-07-9) is a prominent tyrosine kinase inhibitor predominantly used in cancer research Originating from studies focusing on receptor-mediated cellular pathways AG-1295 specifically targets platelet-derived growth factor receptors (PDGFR) which play a crucial role in cell proliferation and angiogenesis By inhibiting these pathways it effectively disrupts the signaling cascade vital for tumor growth In vitro AG-1295 exhibits activity in the nanomolar to low micromolar range making it a potent agent for various experimental settings Its applications span across cell models including fibroblasts and smooth muscle cells as well as animal studies aimed at understanding disease mechanisms and testing new therapeutic strategies It is also incorporated in drug screening processes to identify potential oncological treatments Experimental concentrations typically depend on the specific research design
Apexbio Technology LLC AG-1406-5MG
AG 1406 (CAS No 71308-34-4) is a prominent agent in the biomedical research category notably used in studying cellular signaling pathways originating from kinase activity modulation It primarily targets specific biochemical pathways associated with cell proliferation and apoptosis In vitro AG 1406 demonstrates activity typically within the nanomolar to low micromolar range indicative of its potent interaction with target proteins This compound is frequently utilized in various cell models and animal studies to explore cancer biology and elucidate mechanisms of drug resistance It is a valuable tool in drug screening processes contributing to the discovery of potential therapeutic agents Experimental concentrations typically depend on the specific research design allowing flexibility in its application and adaptation to diverse experimental setups
TARGETMOL CHEMICALS INC AG-13958 5MG
Also available in 1 mL, 1 mg, 10 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration. Purity 99.84%
Apexbio Technology LLC AG-1295-10MG
AG-1295 (CAS No 71897-07-9) is a prominent tyrosine kinase inhibitor predominantly used in cancer research Originating from studies focusing on receptor-mediated cellular pathways AG-1295 specifically targets platelet-derived growth factor receptors (PDGFR) which play a crucial role in cell proliferation and angiogenesis By inhibiting these pathways it effectively disrupts the signaling cascade vital for tumor growth In vitro AG-1295 exhibits activity in the nanomolar to low micromolar range making it a potent agent for various experimental settings Its applications span across cell models including fibroblasts and smooth muscle cells as well as animal studies aimed at understanding disease mechanisms and testing new therapeutic strategies It is also incorporated in drug screening processes to identify potential oncological treatments Experimental concentrations typically depend on the specific research design
Apexbio Technology LLC AG-1295-25MG
AG-1295 (CAS No 71897-07-9) is a prominent tyrosine kinase inhibitor predominantly used in cancer research Originating from studies focusing on receptor-mediated cellular pathways AG-1295 specifically targets platelet-derived growth factor receptors (PDGFR) which play a crucial role in cell proliferation and angiogenesis By inhibiting these pathways it effectively disrupts the signaling cascade vital for tumor growth In vitro AG-1295 exhibits activity in the nanomolar to low micromolar range making it a potent agent for various experimental settings Its applications span across cell models including fibroblasts and smooth muscle cells as well as animal studies aimed at understanding disease mechanisms and testing new therapeutic strategies It is also incorporated in drug screening processes to identify potential oncological treatments Experimental concentrations typically depend on the specific research design
Apexbio Technology LLC AG-1406-25MG
AG 1406 (CAS No 71308-34-4) is a prominent agent in the biomedical research category notably used in studying cellular signaling pathways originating from kinase activity modulation It primarily targets specific biochemical pathways associated with cell proliferation and apoptosis In vitro AG 1406 demonstrates activity typically within the nanomolar to low micromolar range indicative of its potent interaction with target proteins This compound is frequently utilized in various cell models and animal studies to explore cancer biology and elucidate mechanisms of drug resistance It is a valuable tool in drug screening processes contributing to the discovery of potential therapeutic agents Experimental concentrations typically depend on the specific research design allowing flexibility in its application and adaptation to diverse experimental setups